Bristol-Myers Squibb (BMY) Misses Q2 EPS by 23c, Lowers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $61.00 -1.1%
EPS Growth %: -33.1%
Financial Fact:
Net Earnings Attributable to Bristol-Myers Squibb Company: 1.2B
Today's EPS Names:
OMID, BCML, CZNC, More
EPS Growth %: -33.1%
Financial Fact:
Net Earnings Attributable to Bristol-Myers Squibb Company: 1.2B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $1.75, $0.23 worse than the analyst estimate of $1.98. Revenue for the quarter came in at $11.2 billion versus the consensus estimate of $11.81 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2023 EPS of $7.35-$7.65, versus the consensus of $7.99.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Winnebago Industries (WGO) Misses Q4 EPS by 2c; offers guidance
- Equity Lifestyle Properities (ELS) Misses Q3 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
